Endoscopic Extirpation of Benign Breast Tumors Using a Lateral Chest Wall Incision

NCT06472700 | Completed

• 1 other identifier: SunYatsenU8H
• Study Type: observational
• Target: 42
• Locations: 1 country
• Sites: 1

Brief Summary

1. 1.A new surgical method for breast surgery has been introduced, which involves the removal of benign breast tumors through endoscopic surgery, thereby avoiding noticeable scarring on the breast.
2. 2.The feasibility of this surgery, key technical points, and potential complications have been analyzed.

Conditions

Endoscopic Breast Surgery; Benign Breast Tumors

Outcome Measures

Primary Outcomes (1)

• Cosmetic Outcome After Endoscopic Benign Breast Tumor Resection

  Through outpatient questionnaires and physician-rated photo evaluations

  1-3 months post-surgery.

Study Arms (1)

observation group

Other: No intervention

Interventions

No intervention OTHER

No intervention

observation group

Eligibility Criteria

• Age: 14 Years - 42 Years
• Sex: female
• Healthy Volunteers: Yes
• Age Groups: Child (0-17), Adult (18-64)
• Sampling Method: Non-Probability Sample

Study Population

The study population consisted of patients diagnosed with benign breast tumors. The demographic characteristics included: Age: Patients aged 14-42 years old Gender: Female Ethnicity: Diverse ethnic backgrounds, primarily Han Chinese Inclusion Criteria: 1. Female breast benign tumor patients 2. Received endoscopic resection of benign breast tumors via a lateral chest wall approach. Exclusion Criteria: Patients who are unable to comply with follow-up requirements Sample Size: A total of 42 patients were included in the study Geographical Location: Patients were recruited from Sun Yat-sen Memorial Hospital of Sun Yat-sen University

You may qualify if:

• Female breast benign tumor patients
• Received endoscopic resection of benign breast tumors via a lateral chest wall approach.

You may not qualify if:

• Patients who are unable to comply with follow-up requirements
• Patients with a history of breast sugery
• Breast cancer patients

Sponsors & Collaborators

• Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University: lead

Study Sites (1)

Sun Yat-sen Memorial Hospital of Sun Yat-sen University

Guangzhou, Guangdong, 510000, China

Location

Study Design

• Study Type: observational
• Observational Model: COHORT
• Time Perspective: RETROSPECTIVE
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr.

Study Record Dates

• First Submitted: June 15, 2024
• First Posted: June 25, 2024
• Study Start: October 1, 2021
• Primary Completion: August 31, 2023
• Study Completion: November 30, 2023
• Last Updated: June 25, 2024

Record last verified: 2024-06

Locations

CN (1)